CompletedNot Applicable

Remote Ischemic Preconditioning During Lower Limb Revascularization

Italy50 participantsStarted 2018-01-15

Plain-language summary

The aim of this study is to evaluate the role of remote ischemic preconditioning (RIPC) in preventing acute kidney injury after lower limb revascularization. Remote ischemic preconditioning(RIPC) is a simple, cost-free and non invasive procedure (transient upper limb ischemia/reperfusion) that could provide organ protection (Heart, Brain and Kidney) following ischemia injuries.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients scheduled for open limb revascularization Exclusion Criteria: * Peripheral vascular disease affecting upper limbs * Chronic kidney disease in stage 4 or 5 (eGFR\<30 ml/min/1,73m2) * Patients underwent contrast-enhanced radiological exams in the previous 7 days * Treatment with glibencamide or prostaglandins

What they're measuring

AKI

Timeframe: 72 Hours

AKI

Timeframe: 72 Hours

Trial details

NCT IDNCT04016857

SponsorUniversity of Messina

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-01-15

View on ClinicalTrials.gov More Ischemic Preconditioning trials